These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32674793)

  • 1. Congenital Heart Block in Subsequent Pregnancies of SSA/Ro-Positive Mothers: Cutting Recurrence in Half.
    Strasburger JF; Wacker-Gussmann A
    J Am Coll Cardiol; 2020 Jul; 76(3):303-305. PubMed ID: 32674793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
    Izmirly P; Kim M; Friedman DM; Costedoat-Chalumeau N; Clancy R; Copel JA; Phoon CKL; Cuneo BF; Cohen RE; Robins K; Masson M; Wainwright BJ; Zahr N; Saxena A; Buyon JP
    J Am Coll Cardiol; 2020 Jul; 76(3):292-302. PubMed ID: 32674792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases.
    Fredi M; Argolini LM; Angeli F; Trespidi L; Ramoni V; Zatti S; Vojinovic T; Donzelli D; Gazzola FG; Xoxi B; Andreoli L; Lojacono A; Ferrazzi E; Montecucco C; Chighizola CB; Meroni PL; Franceschini F; Cimaz R; Caporali R; Tincani A; Gerosa M
    Clin Exp Rheumatol; 2023 Mar; 41(3):685-693. PubMed ID: 36377571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.
    Gleicher N; Elkayam U
    Autoimmun Rev; 2013 Sep; 12(11):1039-45. PubMed ID: 23684701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study.
    Brucato A; Doria A; Frassi M; Castellino G; Franceschini F; Faden D; Pisoni MP; Solerte L; Muscarà M; Lojacono A; Motta M; Cavazzana I; Ghirardello A; Vescovi F; Tombini V; Cimaz R; Gambari PF; Meroni PL; Canesi B; Tincani A
    Lupus; 2002; 11(11):716-21. PubMed ID: 12475001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women.
    Brucato A; Frassi M; Franceschini F; Cimaz R; Faden D; Pisoni MP; Muscarà M; Vignati G; Stramba-Badiale M; Catelli L; Lojacono A; Cavazzana I; Ghirardello A; Vescovi F; Gambari PF; Doria A; Meroni PL; Tincani A
    Arthritis Rheum; 2001 Aug; 44(8):1832-5. PubMed ID: 11508435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
    Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
    Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serologic marker for fetal risk of congenital heart block.
    Salomonsson S; Dörner T; Theander E; Bremme K; Larsson P; Wahren-Herlenius M
    Arthritis Rheum; 2002 May; 46(5):1233-41. PubMed ID: 12115229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
    Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
    Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.
    Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingström J; Theander E; Rydberg A; Skogh T; Öhman A; Lundström U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Källberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent congenital heart block in neonatal lupus.
    Escobar MC; Gómez-Puerta JA; Albert D; Ferrer Q; Girona J
    Clin Rheumatol; 2007 Jul; 26(7):1161-3. PubMed ID: 16586043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrioventricular conduction delay in fetuses exposed to anti-SSA/Ro and anti-SSB/La antibodies: a magnetocardiography study.
    Wacker-Gußmann A; Paulsen H; Kiefer-Schmidt I; Henes J; Muenssinger J; Weiss M; Goelz R; Preissl H
    Clin Dev Immunol; 2012; 2012():432176. PubMed ID: 23320018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune congenital heart block: a case report and review of the literature related to pathogenesis and pregnancy management.
    Huang Y; Deng J; Liu J; Yang F; He Y
    Arthritis Res Ther; 2024 Jan; 26(1):8. PubMed ID: 38167489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
    Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
    Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.